Assuming R&D effort has been done, and done well, and there is a huge market....wouldn't this be a candidate for acquisition from an organisation that has the wherewithal to rapidly commercialize, manufacture and distribute. I've been with this company since 2013, and they seem very good at what they do....but commercialization hasn't been demonstrated as a core competence.
Ann: Respiri remains on track for commercialisation, page-9
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.25M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 165814 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 189727 | 2 |
View Market Depth
| Last trade - 16.12pm 30/08/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable